Association between phenotypic features of blasts and the blast percentage in bone marrow of patients with myelodysplastic syndromes

Leukemia Research

Volumn 28, Issue 11, 2004, Pages 1171-1175

  Ogata, Kiyoyuki ^a   Satoh, Chikako ^a   Hyodo, Hideya ^a   Tamura, Hideto ^a   Dan, Kazuo ^a   Yoshida, Yataro ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TAKEDA GENERAL HOSPITAL   (Japan)

Author keywords

acute leukemia transformed from MDS; acute myeloid leukemia; AL MDS; AML; BM; bone marrow; FAB; FCM; flow cytometry; French American British; MDS; MPO; myelodysplastic syndromes; myeloperoxidase; RA; RAEB; refractory anemia; WHO; World Health Organization

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; STEM CELL FACTOR RECEPTOR;

ARTICLE; BLAST CELL; BONE MARROW; CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BONE MARROW CELLS; HUMANS; IMMUNOPHENOTYPING; MYELODYSPLASTIC SYNDROMES;

EID: 4544285364     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.03.014     Document Type: Article

References (14)

1. Yoshida Y., Stephenson J., Mufti G.J. Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia. Int. J. Hematol. 57:1993;87-97
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51:1982;189-199
3. Foucar K., Langdon R.M., Armitage J.O., Olson D.B., Carroll T.J. Jr. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer. 56:1985;553-561
4. Kerkhofs H., Hermans J., Haak H.L., Leeksma C.H. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br. J. Haematol. 65:1987;73-81
5. Sanz G.F., Sanz M.A., Vallespi T., Canizo M.C., Torrabadella M., Garcia S., et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 74:1989;395-408
6. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 89:1997;2079-2088
7. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 100:2002;2292-2302
8. Mathew P., Tefferi A., Dewald G.W., Goldberg S.L., Su J., Hoagland H.C., et al. The 5q-syndrome: a single-institution study of 43 consecutive patients. Blood. 81:1993;1040-1045
9. Ogata K., Nakamura K., Yokose N., Tamura H., Tachibana M., Taniguchi O., et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood. 100:2002;3887-3896
10. Cason J.D., Trujillo J.M., Estey E.H., Huh Y.O., Freireich E.J., Stass S.A. Peripheral acute leukemia: high peripheral but low-marrow blast count. Blood. 74:1989;1758-1761
11. Borowitz M.J., Guenther K.L., Shults K.E., Stelzer G.T. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am. J. Clin. Pathol. 100:1993;534-540
12. Loken MR, Wells DA. Normal antigen expression in hematopoiesis. Basis for interpreting leukemia phenotypes. In: Stewart CC, Nicholson JKA, editors. Immunophenotyping. New York: Wiley-Liss; 2000. p. 133.
13. Cossman J., Neckers L.M., Leonard W.J., Greene W.C. Polymorphonuclear neutrophils express the common acute lymphoblastic leukemia antigen. J. Exp. Med. 157:1983;1064-1069
14. Chabannon C., Wood P., Torok S.B. Expression of CD7 on normal human myeloid progenitors. J. Immunol. 149:1992;2110-2113